Search

Kraig M Yager

from Murray, UT
Age ~60
Get Report
Also known as:
Kraig Merlin Yager, Yager M Yager, Kraig M Yeager, Kraig Place
Phone and address:
633 E Lincoln Pl, Salt Lake City, UT 84107
(801) 209-2225
Related to:
Christopher C Yager, 54Joseph GenzardiEleanor KnightMichael Davis, 56Eleanor Knight
Connected to:
Alice M Yager, 98Anita M Yager, 70Ann M Yager, 55Bob L Yager, 96Carolyn P Yager, 76Celeste H Yager, 67Charlotte C Yager, 88Claire T Yager, 79Daniel R Yager, 64Emily Yager, 41

Kraig Yager Phones & Addresses

  • 633 E Lincoln Pl, Salt Lake Cty, UT 84107 (801) 209-2225
  • 633 Lincoln St, Murray, UT 84107 (801) 263-0362
  • Salt Lake City, UT
  • Sandy, UT
  • Oceanside, CA
  • 6832 Skipley Rd, Snohomish, WA 98290
  • Carlsbad, CA
  • San Carlos, CA
  • Bensalem, PA
  • Lake Stevens, WA
  • Bothell, WA
  • 633 E Lincoln Pl, Salt Lake City, UT 84107

Work

Company: Merck Jul 2019 Position: Director, oncology medical science liaison

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Oregon State University 1987 to 1993 Specialities: Organic Chemistry

Skills

Drug Discovery • Ind • Chemistry • Clinical Development • Drug Design • Pharmaceutical Industry • Cro • Pharmacokinetics • Organic Chemistry • Technology Transfer • Biotechnology • Gmp • Organic Synthesis • Fda • Adme • Oncology • Toxicology • Glp • Lead Change • R&D • Pharmaceutics • Parallel Synthesis • Synthetic Organic Chemistry • Dmpk • Formulation • Pharmacology • Clinical Trials • Assay Development • High Throughput Screening • Regulatory Submissions • Drug Metabolism • Biopharmaceuticals • Clinical Research • Cmc • Infectious Diseases • Proteomics • Hplc • Lc Ms • Chromatography • Drug Delivery • Drug Development • Lifesciences • Small Molecules

Industries

Pharmaceuticals

Resumes

Resumes

Kraig Yager Photo 1

Director, Oncology Medical Science Liaison

View page
Location:
6312 south Colleton Cir, Salt Lake City, UT 84121
Industry:
Pharmaceuticals
Work:
Merck
Director, Oncology Medical Science Liaison
Tesaro, Inc.
Oncology Medical Science Liaison
Myriad Genetics Jan 2014 - Apr 2017
Medical Science Liaison, Oncology Medical Affairs
Comprehensive Cmc Outsourcing Mar 1, 2012 - Jan 2014
Principal Partner and Consultant
Myrexis, Inc. Jan 2009 - Apr 2012
Senior Director, Head of Chemistry
Education:
Oregon State University 1987 - 1993
Doctorates, Doctor of Philosophy, Organic Chemistry University of Arizona 1983 - 1987
Skills:
Drug Discovery
Ind
Chemistry
Clinical Development
Drug Design
Pharmaceutical Industry
Cro
Pharmacokinetics
Organic Chemistry
Technology Transfer
Biotechnology
Gmp
Organic Synthesis
Fda
Adme
Oncology
Toxicology
Glp
Lead Change
R&D
Pharmaceutics
Parallel Synthesis
Synthetic Organic Chemistry
Dmpk
Formulation
Pharmacology
Clinical Trials
Assay Development
High Throughput Screening
Regulatory Submissions
Drug Metabolism
Biopharmaceuticals
Clinical Research
Cmc
Infectious Diseases
Proteomics
Hplc
Lc Ms
Chromatography
Drug Delivery
Drug Development
Lifesciences
Small Molecules

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kraig M. Yager
Manager
Nutrichemia , LLC
Business Services at Non-Commercial Site · Nonclassifiable Establishments
633 Lincoln Pl, Salt Lake City, UT 84107

Publications

Us Patents

Anti-Bacterial Agents Based Upon Oxoanion Binding

View page
US Patent:
6737415, May 18, 2004
Filed:
Aug 22, 2002
Appl. No.:
10/227327
Inventors:
Stephen R. Cooper - Carlsbad CA
Kraig M. Yager - Oceanside CA
Assignee:
Quorex Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K 3169
US Classification:
514 64
Abstract:
Compounds of the structure I: are useful for treating bacterial growth, wherein E is selected from the group consisting of B, P, and S, T , and T are each independently selected from the group consisting of O, NR, and CH , where R=H or C -C alkyl, or C -C oxoalkyl, and L is selected from the group consisting of ethylene, propylene, and four to six-membered alicyclic and aromatic rings, provided that structure I does not include AI-2-borate. The compounds may be used to treat bacterial infections in human beings and to regulate biofilm formation. Pharmaceutical compositions comprising one or more such compounds are useful for treating bacterial infections in human beings.

Gyrase Inhibitors

View page
US Patent:
6984652, Jan 10, 2006
Filed:
May 17, 2004
Appl. No.:
10/848474
Inventors:
Kraig Yager - Oceanside CA, US
Shaosong Chu - Encinitas CA, US
Krzysztof Appelt - Rancho Santa Fe CA, US
Xiaoming Li - San Diego CA, US
Assignee:
Warner-Lambert Company LLC - Ann Arbor MI
International Classification:
A61K 31/427
C07D 417/04
C07D 401/14
US Classification:
514365, 514316, 514338, 514318, 51425301, 51425501, 5142375, 5142388, 5142355, 5142368, 514269, 51421108, 540575, 544369, 544133, 544333, 544124, 544364, 5462704, 546193, 546187, 548181
Abstract:
Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.

Anti-Bacterial Agents Based Upon Oxoanion Binding

View page
US Patent:
7074776, Jul 11, 2006
Filed:
Oct 1, 2003
Appl. No.:
10/676770
Inventors:
Stephen R. Cooper - Carlsbad CA, US
Kraig M. Yager - Oceanside CA, US
Assignee:
Quorex Pharmaceuticals, Inc. - Carlsbad CA
International Classification:
A61K 31/69
A61K 31/66
A61K 31/41
A61K 31/425
A61K 31/38
US Classification:
514 64, 514110, 514111, 514363, 514364, 514365, 514372, 514438, 514441
Abstract:
Compounds of the structure I:.

Pharmaceutical Uses And Synthesis Of Nicotinanilide-N-Oxides

View page
US Patent:
7141590, Nov 28, 2006
Filed:
Dec 12, 2001
Appl. No.:
10/015861
Inventors:
Neil S Cutshall - Everett WA, US
Kraig M Yager - Snohomish WA, US
Assignee:
UCB SA - Slough
International Classification:
A61K 31/4412
C07D 211/94
US Classification:
514358, 546347
Abstract:
Disclosed are nicotinanilide-N-oxide compounds, methods for their production, pharmaceutical compositions which include these compounds, and methods for their use in various therapies.

Pyrimidinecarboxamide Derivatives And Their Use As Anti-Inflammatory Agents

View page
US Patent:
7176310, Feb 13, 2007
Filed:
Apr 4, 2003
Appl. No.:
10/407870
Inventors:
Theodore A. Baughman - Bothell WA, US
Jim P. Boyce - Kirkland WA, US
Ihab S. Darwish - Seattle WA, US
J. Jeffry Howbert - Bellevue WA, US
Nathan C. Ihle - Mercer Island WA, US
Randy W. Jackson - Snohomish WA, US
Scott C. Jeffrey - Everett WA, US
Dean Maeda - Bothell WA, US
Kraig M. Yager - Snohomish WA, US
Assignee:
UCB SA - Slough
International Classification:
C07D 239/00
C07D 239/70
US Classification:
544253, 544243, 544245, 544246, 544247, 544249, 544294, 544295
Abstract:
This invention is directed to compound of the following formula (I):.

Anti-Bacterial Agents Based Upon Oxoanion Binding

View page
US Patent:
7326695, Feb 5, 2008
Filed:
May 17, 2006
Appl. No.:
11/435978
Inventors:
Stephen R. Cooper - Carlsbad CA, US
Kraig M. Yager - Oceanside CA, US
Assignee:
The Trustees of Princeton University - Princeton NJ
International Classification:
A01N 55/08
A01N 57/36
A01N 43/82
A01N 43/78
A01N 43/80
A01N 43/06
A01N 43/26
US Classification:
514 64, 514110, 514111, 514363, 514364, 514365, 514372, 514438, 514441
Abstract:
Compounds of the structure I:.

Pharmaceutical Uses And Synthesis Of Nicotinanilide-N-Oxides

View page
US Patent:
20050026965, Feb 3, 2005
Filed:
Feb 17, 2004
Appl. No.:
10/781340
Inventors:
Neil Cutshall - Everett WA, US
Kraig Yager - Snohomish WA, US
Assignee:
Darwin Discovery Limited - Slough
International Classification:
C07D213/56
A61K031/445
US Classification:
514343000, 514350000, 546268100, 546316000
Abstract:
Disclosed are nicotinanilide-N-oxide compounds, methods for their production, pharmaceutical compositions which include these compounds, and methods for their use in various therapies.

Gyrase Inhibitors

View page
US Patent:
20050250823, Nov 10, 2005
Filed:
Jul 7, 2005
Appl. No.:
11/176156
Inventors:
Kraig Yager - Oceanside CA, US
Shaosong Chu - Encinitas CA, US
Krzysztof Appelt - Rancho Santa Fe CA, US
Xiaoming Li - San Diego CA, US
International Classification:
C07D417/04
A61K031/427
US Classification:
514365000, 548181000
Abstract:
Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
Control profile
Kraig M Yager from Murray, UT, age ~60 Get Report